Optiver Holding B.V. Vaxcyte, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 639 shares of PCVX stock, worth $29,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
639
Previous 546
17.03%
Holding current value
$29,176
Previous $17,000
35.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PCVX
# of Institutions
312Shares Held
140MCall Options Held
199KPut Options Held
130K-
Janus Henderson Group PLC London, X014.7MShares$671 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$563 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$546 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$454 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$274 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.71B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...